Summary
Global
Markets Direct's, 'Midkine (Amphiregulin Associated Protein or Midgestation And
Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) - Pipeline
Review, H2 2016', provides in depth analysis on Midkine (Amphiregulin
Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth
Promoting Factor 2 or MDK) targeted pipeline therapeutics.
The
report provides comprehensive information on the Midkine (Amphiregulin
Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth
Promoting Factor 2 or MDK) , targeted therapeutics, complete with analysis by
indications, stage of development, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases. Additionally, the
report provides an overview of key players involved in Midkine (Amphiregulin
Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth
Promoting Factor 2 or MDK) targeted therapeutics development and features
dormant and discontinued projects.
No comments:
Post a Comment